This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Philippe Yves-Remy Simon, Vita Api. Active years: 2021.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2021
Title: Didier Siri: Innovator in Cancer and Neurodegenerative Disorder Treatments
Introduction
Didier Siri is a notable inventor based in Marseille, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer and neurodegenerative disorders. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving medical treatments.
Latest Patents
Didier Siri holds a patent for "Proteasome inhibiting β-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders." This invention relates to proteasome inhibiting β-lactam compounds that are beneficial in treating these serious health conditions. The patent also includes pharmaceutical compositions and extended release formulations of these compounds, highlighting their medical uses in combating cancer and neurodegenerative disorders.
Career Highlights
Throughout his career, Didier has worked with various companies, including Philippe Yves-Remy Simon and Vita Api. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Didier has collaborated with notable individuals in his field, including Gérard Audran and Marvin Schulz. These partnerships have further enhanced his work and expanded the impact of his inventions.
Conclusion
In summary, Didier Siri is a distinguished inventor whose work in developing proteasome inhibiting compounds has the potential to transform treatments for cancer and neurodegenerative disorders. His contributions to the pharmaceutical industry are invaluable and reflect his commitment to advancing medical science.